(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CHO PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CHO PHARMA

ST13

US500000098007393

Class

5

Filing

98007393

Registration

7532266

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

10/08/2024

Trademark type

Combined

Nice classes

5

Filing date

05/22/2023

Registration date

10/08/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/08/2024

Last transaction

10/08/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

Drawing code

3

Owner type

03

Owner location

Taipei City, TW

Examiner

CARROLL, DORITT

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the words "CHO PHARMA" with "O" in "CHO" being a swirled design.

Holders and representatives

Holders

CHO PHARMA INC.

Representatives

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for human purposesmedicines for the treatment of tumorscancersimmune diseasesdisordersinfections and metabolic diseases; Veterinary preparations for the treatment of tumorscancersimmune diseasesdisordersinfections and metabolic diseases; Vaccines; Pharmaceutical preparations for human use for the prevention of tumorscancersimmune diseasesdisordersinfections and metabolic diseases; Biological preparations for medical purposes for the treatment of tumorscancersimmune diseasesdisordersinfections and metabolic diseases; Medicines in the form of capsules for the treatment of tumorscancersimmune diseasesdisorders infections and metabolic diseases; Veterinary preparations for the treatment of tumorscancersimmune diseases/disordersinfections and metabolic diseases; Nutritional supplements; Dietary supplements for human health; Nutritional supplements for medical purposes for boosting human energypromoting human health; Chemical preparations for pharmaceutical purposesthe treatment of tumorscancersimmune diseasesdisordersinfections and metabolic diseases; Chemical preparations for medical purposesfor the treatment of tumorscancersimmune diseasesdisordersinfections and metabolic diseases; Chemical preparations for veterinary purposes namelyfor the treatment of tumorscancersimmune diseasesdisordersinfections and metabolic diseases; Vitamin nutritional supplements; Plant extract nutritional supplements; Diagnostic preparations for medical purposes; Surgical implants comprising of living tissues; Surgical adhesive tapes; Surgical dressings; Preparations for the treatment of burns

Publications

History of USPTO decisions and trademark events.

15 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/08/2024

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

10/08/2024

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

09/03/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/03/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/03/2024

ALIE

ASSIGNED TO LIE

09/03/2024

ALIE

ASSIGNED TO LIE

08/29/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/26/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/14/2024

GNRT

NON-FINAL ACTION E-MAILED

02/14/2024

CNRT

NON-FINAL ACTION WRITTEN

02/14/2024

DOCK

ASSIGNED TO EXAMINER

02/14/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/24/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/23/2023

NWAP

NEW APPLICATION ENTERED

05/25/2023

Continuous trademark protection

Get notified about every new filing that threatens CHO PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.